{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:04:43Z","timestamp":1766023483901,"version":"3.48.0"},"reference-count":25,"publisher":"e-Century Publishing Corporation","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/kkmb6772","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:28:32Z","timestamp":1756373312000},"page":"5949-5961","source":"Crossref","is-referenced-by-count":0,"title":["Albumin ratio and liver-to-abdominal area ratio are promising prognostic indicators for patients with post-hepatitis B cirrhosis"],"prefix":"10.62347","volume":"17","author":[{"given":"Xin","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3390\/v16050724","article-title":"Hepatitis B virus infection: a mini review","volume":"16","author":"Asandem","year":"2024","unstructured":"Asandem DA, Segbefia SP, Kusi KA and Bonney JHK. Hepatitis B virus infection: a mini review. Viruses 2024; 16: 724.","journal-title":"Viruses"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I and Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74: 229-263.","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ijid.2022.06.017","article-title":"Trends in the disease burden of HBV and HCV infection in China from 1990-2019","volume":"122","author":"Yue","year":"2022","unstructured":"Yue T, Zhang Q, Cai T, Xu M, Zhu H, Pourkarim MR, De Clercq E and Li G. Trends in the disease burden of HBV and HCV infection in China from 1990-2019. Int J Infect Dis 2022; 122: 476-485.","journal-title":"Int J Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41591-023-02782-x","article-title":"Real-world implementation of a multilevel interventions program to prevent mother-to-child transmission of HBV in China","volume":"30","author":"Yin","year":"2024","unstructured":"Yin X, Wang W, Chen H, Mao Q, Han G, Yao L, Gao Q, Gao Y, Jin J, Sun T, Qi M, Zhang H, Li B, Duan C, Cui F, Tang W, Chan P, Liu Z and Hou J; SHIELD Study Group. Real-world implementation of a multilevel interventions program to prevent mother-to-child transmission of HBV in China. Nat Med 2024; 30: 455-462.","journal-title":"Nat Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J and Kamath PS. Burden of liver diseases in the world. J Hepatol 2019; 70: 151-171.","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","article-title":"Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"7","author":"2019 Hepatitis B Collaborators","year":"2022","unstructured":"GBD 2019 Hepatitis B Collaborators. Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet Gastroenterol Hepatol 2022; 7: 796-829.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2021.06.018","article-title":"Towards a new definition of decompensated cirrhosis","volume":"76","author":"D&#x2019","year":"2022","unstructured":"D’Amico G, Bernardi M and Angeli P. Towards a new definition of decompensated cirrhosis. J Hepatol 2022; 76: 202-207.","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Tandon P, Montano-Loza AJ, Lai JC, Dasarathy S and Merli M. Sarcopenia and frailty in decompensated cirrhosis. J Hepatol 2021; 75 Suppl 1: S147-S162.","DOI":"10.1016\/j.jhep.2021.01.025"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1001\/jamasurg.2022.4149","article-title":"Sex-adjusted model for end-stage liver disease scores for liver transplant allocation","volume":"157","author":"NL","year":"2022","unstructured":"Wood NL, Segev DL and Gentry SE. Sex-adjusted model for end-stage liver disease scores for liver transplant allocation. JAMA Surg 2022; 157: 1166-1167.","journal-title":"JAMA Surg"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/cpt.3265","article-title":"Hepatic dysfunction quantified by hepquant DuO outperforms child-pugh classification in predicting the pharmacokinetics of ampreloxetine","volume":"116","author":"Kanodia","year":"2024","unstructured":"Kanodia J, Giovinazzo H, Yates W, Bourdet DL, McRae MP, Helmke SM and Everson GT. Hepatic dysfunction quantified by hepquant DuO outperforms child-pugh classification in predicting the pharmacokinetics of ampreloxetine. Clin Pharmacol Ther 2024; 116: 186-193.","journal-title":"Clin Pharmacol Ther"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1097\/CORR.0000000000002631","article-title":"Child-pugh class B or C liver disease increases the risk of early mortality in patients with hepatitis C undergoing elective total joint arthroplasty regardless of treatment status","volume":"481","author":"Cichos","year":"2023","unstructured":"Cichos KH, Jordan E, Niknam K, Chen AF, Hansen EN, McGwin G Jr and Ghanem ES. Child-pugh class B or C liver disease increases the risk of early mortality in patients with hepatitis C undergoing elective total joint arthroplasty regardless of treatment status. Clin Orthop Relat Res 2023; 481: 2016-2025.","journal-title":"Clin Orthop Relat Res"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Tarannum S, Ilyas T, Tarannum Shaik S, Sultana N, Saniya MN, Mynampati AM, Nayak KA, Gogikar S and Kumar R. Assessment of the child-pugh score, model for end-stage liver disease score, fibrosis-4 index, and AST to platelet ratio index as non-endoscopic predictors of the presence of esophageal varices and variceal bleeding in chronic liver disease patients. Cureus 2024; 16: e73768.","DOI":"10.7759\/cureus.73768"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Li B, Hou X, Ning B, Li X, Zhang M, Wang J, Liu M, Shi Y and Kang Z. Predictive role of the peripheral blood inflammation indices neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immunoinflammatory index (SII) for age-related cataract risk. PLoS One 2024; 19: e0313503.","DOI":"10.1371\/journal.pone.0313503"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1111\/apt.12529","article-title":"The liver to abdominal area ratio (LAAR): a novel imaging score for prognostication in cirrhosis","volume":"38","author":"Cross","year":"2013","unstructured":"Cross TJ, Joseph M, Fernando RA, Farrell C and Mitchell JD. The liver to abdominal area ratio (LAAR): a novel imaging score for prognostication in cirrhosis. Aliment Pharmacol Ther 2013; 38: 1385-1394.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.14218\/jcth.2023.00320","article-title":"Guidelines for the prevention and treatment of chronic hepatitis B (version 2022)","volume":"11","author":"You","year":"2023","unstructured":"You H, Wang F, Li T, Xu X, Sun Y, Nan Y, Wang G, Hou J, Duan Z, Wei L, Jia J and Zhuang H; Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B (version 2022). J Clin Transl Hepatol 2023; 11: 1425-1442.","journal-title":"J Clin Transl Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"7088","DOI":"10.3748\/wjg.v26.i45.7088","article-title":"Chinese guidelines on the management of liver cirrhosis (abbreviated version)","volume":"26","author":"XY","year":"2020","unstructured":"Xu XY, Ding HG, Li WG, Xu JH, Han Y, Jia JD, Wei L, Duan ZP, Ling-Hu EQ and Zhuang H. Chinese guidelines on the management of liver cirrhosis (abbreviated version). World J Gastroenterol 2020; 26: 7088-7103.","journal-title":"World J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"7268459","DOI":"10.1155\/2020\/7268459","article-title":"Neutrophil-to-lymphocyte ratio and albumin: new serum biomarkers to predict the prognosis of male alcoholic cirrhosis patients","volume":"2020","author":"Zhang","year":"2020","unstructured":"Zhang M, Zhang Y, Liu L, Prithweeraj M, Xu H, Wu R, Wen X and Niu J. Neutrophil-to-lymphocyte ratio and albumin: new serum biomarkers to predict the prognosis of male alcoholic cirrhosis patients. Biomed Res Int 2020; 2020: 7268459.","journal-title":"Biomed Res Int"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Han Z, He X and Peng S. Neutrophil count to albumin ratio as a prognostic indicator for HBV-associated decompensated cirrhosis. J Clin Lab Anal 2021; 35: e23730.","DOI":"10.1002\/jcla.23730"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"20759","DOI":"10.1038\/s41598-023-44842-9","article-title":"Prognostic value of neutrophil count to albumin ratio in patients with decompensated cirrhosis","volume":"13","author":"Yao","year":"2023","unstructured":"Yao J, Xu X, Gong K, Tu H, Xu Z, Ye S, Yu X, Lan Y, Weng H and Shi Y. Prognostic value of neutrophil count to albumin ratio in patients with decompensated cirrhosis. Sci Rep 2023; 13: 20759.","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Yuan MC, Mao WE, He X and Zhang Q. Novel marker for predicting prognosis in hepatitis B virus-associated decompensated cirrhosis: monocyte-to-albumin ratio. Clin Lab 2023; 69.","DOI":"10.7754\/Clin.Lab.2023.230204"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/MEG.0000000000001339","article-title":"Prognostic value of international normalized ratio to albumin ratio among critically ill patients with cirrhosis","volume":"31","author":"Gao","year":"2019","unstructured":"Gao F, Cai MX, Lin MT, Xie W, Zhang LZ, Ruan QZ and Huang ZM. Prognostic value of international normalized ratio to albumin ratio among critically ill patients with cirrhosis. Eur J Gastroenterol Hepatol 2019; 31: 824-831.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref21","unstructured":"Chen J, Lin S and Zhu Y. Liver to abdominal area ratio in prognosis prediction in alcohol-induced acute-on-chronic liver failure. Zhonghua Yi Xue Za Zhi 2016; 96: 801-806."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1080\/00325481.2017.1327781","article-title":"Liver-to-abdominal area ratio for predicting the in-hospital mortality in advanced liver cirrhosis","volume":"129","author":"Gao","year":"2017","unstructured":"Gao F, Wang R, Deng H, Hou F, Romeiro FG and Qi X. Liver-to-abdominal area ratio for predicting the in-hospital mortality in advanced liver cirrhosis. Postgrad Med 2017; 129: 756-761.","journal-title":"Postgrad Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12893-022-01789-4","article-title":"Novel postoperative nomograms for predicting individual prognoses of hepatitis B-related hepatocellular carcinoma with cirrhosis","volume":"22","author":"Xu","year":"2022","unstructured":"Xu L, Dai F, Wang P, Li L, Zhang M and Xu M. Novel postoperative nomograms for predicting individual prognoses of hepatitis B-related hepatocellular carcinoma with cirrhosis. BMC Surg 2022; 22: 339.","journal-title":"BMC Surg"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.2147\/IJGM.S323293","article-title":"The combination of age, international standardized ratio, albumin and γ-glutamyl transpeptidase (AIAG), tumor size and alpha fetoprotein (AFP) stage as the prognostic model for hepatitis B-related hepatocellular carcinoma","volume":"14","author":"Liu","year":"2021","unstructured":"Liu S, Xu Z, Fang Z, Zhang D, Qin Z, Fan L, Duan J, Yin H, Zhang Y, Pang Q and Tan Y. The combination of age, international standardized ratio, albumin and γ-glutamyl transpeptidase (AIAG), tumor size and alpha fetoprotein (AFP) stage as the prognostic model for hepatitis B-related hepatocellular carcinoma. Int J Gen Med 2021; 14: 4291-4301.","journal-title":"Int J Gen Med"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/8\/ajtr0163010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:00:00Z","timestamp":1766023200000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/8\/ajtr0163010.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":25,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/kkmb6772","relation":{},"ISSN":["1943-8141"],"issn-type":[{"type":"electronic","value":"1943-8141"}],"subject":[],"published":{"date-parts":[[2025]]}}}